0001209191-20-013032.txt : 20200226 0001209191-20-013032.hdr.sgml : 20200226 20200226163525 ACCESSION NUMBER: 0001209191-20-013032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200224 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parini Michael CENTRAL INDEX KEY: 0001661567 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20656294 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-24 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001661567 Parini Michael C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CL&AO Common Stock 2020-02-24 4 F 0 2416 239.23 D 29866 D Common Stock 2020-02-25 4 S 0 938 230.07 D 28928 D Common Stock 2020-02-25 4 S 0 330 231.62 D 28598 D Common Stock 2020-02-25 4 S 0 320 232.89 D 28278 D Common Stock 2020-02-25 4 S 0 640 234.77 D 27638 D Common Stock 2020-02-25 4 S 0 320 236.26 D 27318 D Common Stock 2020-02-25 4 S 0 480 238.30 D 26838 D Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $230.07 (range $229.75 to $230.57). Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $231.62 (range $231.12 to $232.06). Open market sales reported on this line occurred at a weighted average price of $232.89 (range $232.73 to $233.05). Open market sales reported on this line occurred at a weighted average price of $234.77 (range $234.51 to $235.46). Open market sales reported on this line occurred at a weighted average price of $236.26 (range $235.72 to $236.80). Open market sales reported on this line occurred at a weighted average price of $238.30 (range $238.16 to $238.54). /s/ Omar White, Attorney-in-Fact 2020-02-26